Estrogen's role in Alzheimer's disease has been a subject of significant research. Estrogen, a hormone primarily associated with female reproductive health, also influences brain function, including memory and cognition. Studies suggest that estrogen may have neuroprotective effects, potentially reducing the risk of Alzheimer's disease in women. However, the relationship is complex, as estrogen's benefits seem to vary depending on age, timing of hormone exposure (such as menopausal status), and individual genetic factors. Some research indicates that estrogen therapy after menopause might help maintain cognitive function and reduce the risk of dementia. Yet, the use of estrogen therapy remains controversial due to associated risks, such as cardiovascular complications and certain types of cancer. Further research is crucial to clarify estrogen's precise role in Alzheimer's disease and to develop safer therapeutic strategies.
Title : Cerebral vascular calcium signaling in diabetic alzheimer's disease-related dementias
Yong Xiao Wang, Albany Medical College, United States
Title : Deep learning-based risk assessment of cognitive impairment using health examination data
Kaoru Sakatani, The University of Tokyo, Japan
Title : Evaluation of the neuroprotective potential of indicaxanthin from opuntia ficus indica fruit against dysmetabolism-related neurodegeneration both in vivo and in vitro
Mario Allegra, University of Palermo, Italy
Title : Cogs Club: Making a difference
Jacqueline Tuppen, Cogs Club, United Kingdom
Title : Development of imaging based biomarkers for neurovascular abnormalities in neurodegenerative diseases
Jun Hua, Johns Hopkins University School of Medicine, United States
Title : Psychosocial considerations in management of corticobasal degeneration
Esraa Askar, Forest Hills Hospital, United States